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Abstract
Objective: To evaluate the barriers and facilitators to high-quality diabetes care as experienced
by general practitioners (GPs) who participated in an 18-month quality improvement program
(QIP). This QIP was implemented to promote compliance with international guidelines.
Methods:  Twenty out of the 120 participating GPs in the QIP underwent semi-structured
interviews that focused on three questions: 'Which changes did you implement or did you observe
in the quality of diabetes care during your participation in the QIP?' 'According to your experience,
what induced these changes?' and 'What difficulties did you experience in making the changes?'
Results: Most GPs reported that enhanced knowledge, improved motivation, and a greater sense
of responsibility were the key factors that led to greater compliance with diabetes care guidelines
and consequent improvements in diabetes care. Other factors were improved communication with
patients and consulting specialists and reliance on diabetes nurse educators. Some GPs were
reluctant to collaborate with specialists, and especially with diabetes educators and dieticians.
Others blamed poor compliance with the guidelines on lack of time. Most interviewees reported
that a considerable minority of patients were unwilling to change their lifestyles.
Conclusion: Qualitative research nested in an experimental trial may clarify the improvements
that a QIP may bring about in a general practice, provide insight into GPs' approach to diabetes
care and reveal the program's limits. Implementation of a QIP encounters an array of cognitive,
motivational, and relational obstacles that are embedded in a patient-healthcare provider
relationship.
Introduction
Landmark studies have demonstrated that intensive man-
agement of hyperglycemia, hyperlipidemia, and hyper-
tension significantly reduces morbidity and mortality in
patients with type 2 diabetes mellitus (T2DM) [1-9].
T2DM is a 'silent disease' until irreversible microvascular
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(e.g., nephropathy, retinopathy, diabetic foot) and/or
macrovascular (e.g., myocardial infarction, stroke) com-
plications become apparent. Prevention of these compli-
cations rests on timely institution of drug therapy by the
prescribing physician, usually a general practitioner (GP),
and the patient's compliance with the treatment regimen
and willingness to make lifestyle changes. A proactive fol-
low-up of diabetic patients is essential and should include
foot examinations, blood and urine tests, and eye exami-
nation [10]. In addition, patients should be counseled
about the dangers of diabetes and the importance of a
healthy lifestyle, and impressed with the need for compli-
ance with doctor's orders.
Unfortunately, many patients do not receive such level of
care despite the availability of internationally-accepted
treatment guidelines describing optimal management of
patients with diabetes [11]. Optimal use of guidelines in
general practice demands specific implementation strate-
gies aiming at the reduction of barriers to high-quality
care [12]. However, a clear understanding on how to over-
come these barriers seems to be lacking [13-15], despite
previous studies which outlined the obstacles that prevent
GPs from following the guidelines [16-24]. Our study
reports on 20 GPs who participated in an 18-month qual-
ity improvement program (QIP). The aim of this program
was to improve diabetes-related patient outcomes
through the implementation of evidence-based guideline
recommendations. The different interventions of this QIP
are described in the Appendix. The program resulted in
significant improvements over time of HbA1c (-0.4%, CI
95% (-4;-3)), systolic blood pressure (-3 mmHg, CI 95%
(-4;-1)) and LDL-C (-13 mg/dl, CI 95% (-15;-11)). How-
ever, results widely varied between participating GPs.
Accordingly, we conducted a complementary, qualitative
study (January to April 2008) nested in the controlled
trial, to gain better insight into what changes the GPs had
actually experienced. To fully understand these changes,
we relied on an 'implementation model' based on the one
described by Grol et al., 2004 [25-27].
Methods
We conducted this qualitative research to acquire a better
understanding of the barriers to high-quality diabetes care
and into the mechanisms of change that eventually were
induced by the QIP according to the experience of partic-
ipating GPs. We opted for 'one-on-one' interviews in
order to investigate the perceptions of the GPs about the
QIP that essentially targeted the individual GP. We opted
for semi-structured interviews in order to let the interview-
ees talk freely, as well as to deepen the interviewees' per-
sonal feelings about both the experienced barriers to high-
quality care and facilitators of change.
To gain maximum information, the interviewees were
randomly chosen from a stratified sample of participants
according to clinical performance scores before and after
the intervention. The clinical practices were divided in
four strata relying on baseline performance (stronger ver-
sus weaker) and on the degree of improvement during the
project (modest versus substantial). A researcher not
involved in the interviews randomly chose five GPs within
each stratum. If a selected GP refused to participate, the
next GP on the list in that stratum was invited.
Interviewees and interviewers were blinded to the practice
stratum at the time of the interview. Our design called for
20 interviews with post-hoc analysis and evaluation of data
saturation. Plans were made for additional interviews if
the data saturation criterion was not met. Three main
questions were asked in the semi structured interviews:
'Which changes did you implement or did you observe in
the quality of diabetes care during your participation in
the QIP?' 'According to your experience, what induced
these changes?' and 'What difficulties did you experience
in making the changes?'
Subsequent discussions delved deeper into these topics by
using an adaptation of 'reflective listening', a counseling
technique that elicits a thorough disclosure of the inter-
viewees thoughts and feelings [28]. It involves reflecting
back to the interviewee what the interviewer believes was
said in order to verify or clarify the interviewee's state-
ments, and encourages interviewees to continue elaborat-
ing their views. In our interviews, not only were the
assertions reflected back, the interviewees were also
actively confronted with eventual inconsistencies in their
answers. Throughout, the interviewers provided reassur-
ance by intonation and body language in order to disclose
the very personal feelings and experiences of the inter-
viewees.
The interviews took 30 to 45 minutes and were conducted
individually by two experienced researchers (GG and
LBO), one a practicing GP and the other a community
nurse specializing in health care consultancy. All inter-
views were taped and transcribed.
Before analyzing the transcripts, we discussed the analyti-
cal method to use. We decided to categorize the items by
theory-based deduction using the 'implementation
model' (Grol et al., 2004). We chose this model because it
is based on a comprehensive overview of theories on
implementation and behavioral change. These theories
relate to the individual's cognitive, educational, and moti-
vational attributes, as well as social, organizational, and
economic factors. This model also reflects the basic struc-
ture of the interviews: barriers and facilitators of guideline
implementation are well-described. As such, this modelImplementation Science 2009, 4:41 http://www.implementationscience.com/content/4/1/41
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allows for deductive coding and categorizing of the items
according to the level of action. After a first discussion
round, we reached consensus to categorize the items in
three levels: individual GP, individual patient, and social
interaction, context, and organization. Items were divided
into 'barriers to high-quality diabetes care' and 'factors
facilitating change'. Barriers at the individual level were
further categorized into subcategories of 'knowledge',
'awareness', 'attitude and motivation', 'routine' and 'oth-
ers'. All transcripts were re-read when necessary and inde-
pendently analyzed by GG and LBO to ensure reliability
of the data. Transcripts were manually coded and the
items were categorized using MicroSoft Excel spread-
sheets. Differences in coding were discussed and final
decisions on items and categories were based on a consen-
sus between the two interviewers.
Results
Two GPs refused to participate in the interview and were
replaced by the GP next in line. In a post-hoc analysis, we
found that few new themes were emerging after about 17
interviews, making it unnecessary to continue the inter-
viewing after the 20 initially planned interviews. Table 1
shows the main characteristics of the interviewees that
were felt to be typical of all 120 participants in the QIP.
Table 2 shows the results of itemization that was obtained
in commons consensus by the two researchers.
All but four of the GPs confirmed the importance of
improved adherence to the evidence-based guidelines.
The four GPs who did not experience improved adherence
belonged to a stratum with a stronger baseline perform-
ance, and three of them also belonged to the stratum with
weaker improvement during the project. Three of them
revealed that they had previously followed an intensive
course on diabetes management. The fourth GP is still col-
laborating with the medical faculty of the university. Most
interviewees also reported improvements in follow-up
procedures, evidence-based drug prescription practices,
and referral rates. The more frequent follow-up visits
included regular blood monitoring and general screening
for complications. Several GPs mentioned better record-
keeping.
Implementation of evidence-based treatment was evident
in more timely adjustments in therapy if target criteria fell
short, and in greater attention to cardiovascular risk fac-
tors, above and beyond conventional glycemic control.
Finally, more patients were treated with insulin.
Some interviewees reorganized their practices to better
comply with the guidelines. Others instituted regularly
scheduled office visits, and some split the visits into two
parts: one part dedicated to routine follow-up and the
other to discussions of treatment and lifestyle. The inter-
viewees noted better medication compliance and
improved adherence to follow-up schedules by the
patients.
Barriers to high-quality diabetes care and factors 
facilitating change
Our analysis showed that a first barrier to successful dia-
betes care was GPs inadequate knowledge how to manage
insulin therapy and cardiovascular risk.
'My attitude about insulin therapy onset has changed.
Before the start of the project, I tried too long oral anti dia-
betics, but the courses have changed my attitude. I became
confident in starting insulin therapy, whereas before I
would never initiate insulin therapy. (12-S3)
A second barrier was the GPs' lack of awareness of their
own performance because of 'blind spots'.
'Such a project with follow-up is important because it
obliges you to question yourself. I thought my patients were
reasonably well controlled, but the QIP – especially the
feedback – makes you confront your problems and weak-
nesses.' (3, S1)
Table 1: Principal characteristics of participating GPs
S1
(N = 5)
S2
(N = 5)
S3
(N = 5)
S4
(N = 5)
All interviewees (N = 20) All participants (N = 120)
M e a n  a g e  ( y e a r s ) 4 64 54 83 6 4 4 4 4
Females (N) 1 1 1 3 6 45%
Workplace
Solo practice (N) 3 3 0 1 7 38%
Two man practice (N) 0 2 3 1 6 32%
Group practice (N) 2 0 2 3 7 30%
S1 = Stratum of GPs with weaker baseline performance and modest improvement during the QIP
S2 = Stratum of GPs with weaker baseline performance and substantial improvement during the QIP.
S3 = Stratum of GPs with stronger baseline performance and modest improvement during the QIP.
S4 = Stratum of GPs with stronger baseline performance and substantial improvement during the QIP.Implementation Science 2009, 4:41 http://www.implementationscience.com/content/4/1/41
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Several interviewees also affirmed that before the start of
the project they did not truly understand the importance
of attaining clinical targets and regular follow-ups.
'The constant support and the organized courses made the
difference. The protocol map, which has become a reference
work, also contributed a lot. Because of the feedback, I
became aware that my performance on lipid-lowering ther-
apy was not good. This, together with information on vas-
cular pathology as a major problem in diabetes, made me
change my attitude. I have begun to prescribe more statins.'
(10-S3)
A third barrier, expressed by several interviewees, was the
presence of skepticism about evidence-based treatment
and of collaborative care, and their concerns about losing
control and sanctions that may result from diabetes care
improvement plans.
Table 2: Coded categories and themes
Perceived barriers to optimal diabetes care
Level Factor Item
Physician Lack of knowledge on - global cardiovascular treatment beyond glycemic control
- insulin therapy
Lack of awareness regarding - personal practice performance ('blind spots')
- need to reach treatment targets and regular follow-up
Attitude and motivation - laxity regarding treatment targets and timely follow-up
- attitude to polypharmacy
- skepticism regarding evidence-based treatment, top-down quality improvement 
projects and shared care collaboration
Patient Practice organization - lack of scheduled visits, lack of planned follow-up, lack of support staff
Lack of knowledge on - insight regarding complications, significance of HbA1c
Lack of awareness regarding - personal dietary patterns
- personal health status (HbA1c, blood pressure, cholesterol)
Attitude and motivation - fear of insulin treatment
- lack of motivation for follow-up or to change lifestyle
Routine behavior - maintaining lifestyle change very difficult
- adhering to planned follow-up visits is difficult
Context and organization Age and co-morbidity - too strict control can be dangerous in older patients
- immobility hampers physical exercise and shared care referral
Relationships - between GPs and patients (inertia to change)
- competition between specialists and GPs
Lack of teamwork - Need for clear description of each provider's duties and responsibilities
- Need for identical messages to the patients from all health care providers
Financial barriers - out-of-pocket payments for education, dietary advice and HBGM material
- skewed reimbursement of HBGM material
- fee for service: this system doesn't motivate GPs to deliver high-quality care
Perceived change facilitators
Level of impact Item
Physician Treatment protocol and post-graduate education; Benchmarking feedback
Case coaching; Timely data collection
Increased contact and communication with peers in other disciplines
Participation in team meetings
Attitude change on the part of specialists
Patient Nurse educator and IDCT working as a team
Free services and free materials
Identical messages from different sources (GP, specialist, educator, television
Attitude change on the part of the GP
Context and organization Role redesign and reassignment of responsibilities
Serial removal of barriers
Task relief
HBGM = Home Blood Glucose Monitoring; IDCT = Interdisciplinary Diabetes Care Team (endocrinologist, nurse educator, dietician) installed at 
the primary care levelImplementation Science 2009, 4:41 http://www.implementationscience.com/content/4/1/41
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'I do everything myself. I find it difficult to work in a team,
and I am rather skeptical about the 'soft sector' (psycholo-
gists, educators...)' (11-S3)
'Policymakers should use such programs for positive motiva-
tion. They should not connect results with negative implica-
tions (e.g., loss of accreditation).' (15-S3)
Some GPs considered evidence-based medicine (EBM)
only as background information describing the ideal situ-
ation to strive for, but not as a stringent, compulsory
framework.
'Paper is no reality. EBM is only a supportsupport tool, but
can never be an impsosed framework.' (3-S1)
One GP admitted that he had worked according to a fun-
damentally different paradigm closer to alternative medi-
cine. From this viewpoint he disagreed with the guideline
on many aspects, such as the importance that was given to
lipid control.
'Evidence-based medicine is a relative term...something
might be evidence-based, but I have in mind other param-
eters that are much more important. In my alternative point
of view, I do not care a lot about cholesterol, for example.'
(7-S2)
Some GPs admitted being lax and several indicated that
lack of time – because of suboptimal practice manage-
ment – prevented them from providing good quality care.
'I admit that I was lax before, but have changed during the
project. Some patients were incredibly surprised that finally
they were getting good care.' (7-S2)
'I didn't observe major behavioral changes in most patients,
but this may be associated with my own passive attitude. I
made no changes in my organization of care and I did not
spend enough time at it.' (16-S4)
Several GPs also questioned the feasibility and desirability
of implementing these guidelines in an older diabetes
population.
'Many of my patients are older than 80. I will not forbid
them to eat a piece of cake. Indeed, my own attitude
towards elderly people is a little bit more loose.' (4-S2)
'The recommendations on weight loss and physical activity
are useless for a lot of elderly people who are too ill or immo-
bile to follow them.' (3-S1)
Factors conducive to good care were also discussed. The
consensus was that transparent treatment protocols and
tailored post-graduate courses would go a long way in
overcoming knowledge gaps. Benchmarking feedback
confronted the GPs with their blind spots and weaknesses,
and increased their awareness of shortcomings in their
case management habits. Case coaching was identified as
an important innovation in improving 'knowledge on the
spot', especially in initiating and adapting insulin therapy.
'The extra coaching was unique to this project and func-
tioned like clockwork. You only had to make a phone call –
that is very comforting to a GP.' (12-S3)
Several GPs confirmed that the three-month data collec-
tion exercise encouraged regular recordkeeping and a
structured approach to patient follow-up.
'The imposed recordkeeping of patient data put me under
some pressure. Imposing a structure helps you handle your
job more systematically. Since the project has stopped, this
disciplined approach is beginning to wane again.' (1-S2)
Many GPs also felt that care was compromised by the
patients' insufficient understanding of diabetes, lack of
awareness of serious complications, and of the impor-
tance lifestyle changes. Fear of insulin therapy ('fear of the
needle') was also mentioned. However, these barriers
were perceived as something that could be overcome by
education, especially when provided by well-trained
nurse educators.
'The big change is the availability of the nurse educator...
She really took the time to explain the problem of diabetes.
People have a better understanding of what HbA1c is...peo-
ple are afraid of needle sticks and this fear has decreased
because of the project, thanks to the nurse educator.' (2-S2)
GPs also described the synergistic effect of several health-
care workers delivering the same message in inducing a
sudden change in attitude.
'If three professionals give the same message and if, moreo-
ver, patients receive the same message by television, and
then a sudden change can occur.' (8-S1)
There was consensus that patients' attitudes and lack of
motivation are major barriers to implementing evidence-
based treatment, especially when it involved a change in
lifestyle.
'Physical activity and weight control remain the main prob-
lems. The motivation to change lifestyle habits is often com-
pletely absent. Some patients deny the problem: 'I don't eat
very much'. (9-S2)Implementation Science 2009, 4:41 http://www.implementationscience.com/content/4/1/41
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Finally, GPs felt that about one-third of the patients
would be uncooperative no matter what changes were
proposed, and most GPs agreed that changing entrenched
lifestyle habits was difficult for most patients to achieve,
whatever their initial motivation. For the most part, any
such changes would be small and temporary.
'A minority – about 30% – doesn't want to hear anything.
They won't even go to see the nurse educator. Another 30%
are somewhat motivated, but not too much, and the
remaining 30% really cooperate. The added value of the
project, probably, applies only to patients who are motivated
and who can get motivated.' (2-S2)
GPs also mentioned social, organizational, and legal bar-
riers and facilitating factors. The interaction between a GP
and his or her patients, especially when it concerns a long-
term relationship, can itself hamper the transition to high-
quality diabetes care. Several GPs described how patients
were accustomed to certain situations and habits of their
GPs,  e.g., a limited use of drugs. They did not always
understand or appreciate the sudden change in their GP's
attitude; this led to tensions in some cases and loss of con-
tact in others.
I have started prescribing lipid-lowering drugs relatively
recently. Before the project, I was rather reluctant to prescribe
medications and my patients were not accustomed to my new
attitude. So, I had to take a gradual approach.' (10-S3)
'Previously, some patients probably consulted me because I
was easygoing. Since my participation in the project, I've
pushed them more and so I lost two patients. They frankly
told me 'We're leaving because you exaggerate things.
What's the matter with you?' But patients and physicians
must evolve together, although at a moderate pace.' (7-S2)
However, the project mitigated such unfortunate
instances through counseling sessions involving the GPs,
patients and nurse educators. The net effect was a
strengthening of the physician-patient relationship and a
motivational boost to the latter.
'Diabetes patients themselves feel much more appreciated;
because of that, the link between us and our patients has
strengthened.' (17-S4)
Most GPs held that a lack of a clear delineation of respon-
sibilities leads to competition between the GP and the
specialist, with the latter being perceived as holding the
upper hand. This competition is reinforced by the skewed
reimbursement schemes in Belgium in favor of the spe-
cialist concerning patient education and home blood glu-
cose monitoring (HBGM) kits. This skewed situation was
considered as an important factor that prevents many GPs
from commencing timely insulin therapy.
'Specialists gain too much control of referred patients and
often exclude GPs from direct patient care. This is especially
true of patients on insulin who get free instructions and
monitoring kits at the diabetes centers, unlike patients in
primary care. So, it's nearly impossible for GPs to hold on
to patients on insulin.' (1-S2)
The QIP redefined the GP as a central 'manager' with
explicit responsibilities for the care for patients with dia-
betes.
'To summarize this project: we started with a good protocol
and established better channels of communication between
primary and specialist care....The delineation of responsi-
bilities and degree of familiarity among the partners were
very important in making it easier to me to refer more
patients.' (14-S1)
This was much appreciated by the interviewees. It rein-
forced the GPs' feeling of recognition, boosted self-
esteem, promoted a greater sense of responsibility, and
improved their professional relationships with specialists.
'The project did not merely create the illusion that the GP
was pivotal in diabetes care, he or she actually became the
central figure and this fact increased their job satisfac-
tion....This only became possible because of an attitude
change on the part of the endocrinologists. Now they say
'you GPs have to do the job, but call me when necessary.'
This is a big change from the usual 'let us do our work; after
all we are the specialists and you may help a little bit'. We
collaborate as one team – there's mutual support! We're on
the same wavelength and feel we work together toward the
same objectives.' (13-S4)
Many GPs regarded the role of the nurse educator as com-
plementary to their own and, feeling that they themselves
lacked the requisite skills and time, were relieved to relin-
quish patient education to them.
'I prefer to have the nurse educator bring up insulin therapy
before I get to it....After 30 years in general practice, I'm
somewhat hesitant to get into a protracted struggle with
patients to try to convince them of the need for insulin. 'If
you're not interested, so be it,' I think by myself. The nurse
educator is an invaluable asset in such cases.' (8-S1)
One GP felt that the Belgian fee-for-service scheme was an
important impediment to the delivery of quality care,
explaining that a pay-for-performance system would be a
better motivator. In addition, direct payment by patients
was also seen as a significant factor that discouragedImplementation Science 2009, 4:41 http://www.implementationscience.com/content/4/1/41
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patient referrals and HBGM necessary to evaluate insulin
therapy.
Discussion
Previous studies have disclosed a significant gap between
the quality of diabetes care commonly encountered and
recommended evidence-based guidelines [14]. To date,
most research on barriers to and facilitators of high-qual-
ity care has been done before the start of improvement
programs. Our study was based on interviews with GPs
who actually participated in a project aimed at optimizing
diabetes care. This approach, combined with the 'reflec-
tive listening' technique, elicited disclosure of very per-
sonal feelings and experiences related to changes in
performance. As such, qualitative research nested in an
experimental trial may clarify the improvements that a
QIP brings about in a general practice.
The primary finding was that the project accomplished
more than merely improving the quality of care. It also
impacted the emotional and motivational status of the
GPs. Previous focus group-based research had revealed
that GPs working in the 'usual' setting in our country felt
frustrated, partly because they felt inferior to specialists
[29]. We showed that role-redesign and delineation of
responsibilities vis-à-vis  the specialists enhanced a GP's
self-esteem and sense of responsibility. All interviewees
were unanimous that this project was very beneficial
because it added value to their jobs, even though some
were concerned that QIPs could have manipulative ends
or lead to sanctions.
Second, most of the GPs reported a major improvement
in their diabetes care. According to the theory of planned
behavior, decisions are made according to personal mod-
els and beliefs about the changes about to be made, and
the perceived benefits and risks associated with them [30].
Several GPs indicated that the changes resulted from a
conscious decision based on interconnected key elements
during the quality improvement process. Reported key
elements were the need to keep up with knowledge, the
increased awareness that their practice needs improve-
ment, and that their attitude needs adjustment. The GPs
also observed attitudinal changes in their patients, e.g.,
better adherence to drug regimens and follow-up visits.
Third, a multifaceted QIP may evoke complex changes
that go beyond individual physicians and patients,
because they form an interconnected and interdependent
social continuum. The GPs described cases in which joint
and coherent actions of several health workers effected a
change in a patient's attitude where a solitary GP failed.
The QIP facilitated patient referrals to the nurse educator,
despite certain resistance on the part of some patients or
physicians. The nurse educator, in turn, contributed to
patient care by ensuring follow-ups, providing informa-
tion on insulin therapy and health lifestyles, and perform-
ing complementary examinations, i.e., carrying out
functions for which the GP lacked time or did not possess
adequate skills or motivation. This task delegation
allowed the GPs both to sustain their ongoing relation-
ship with the patients and to concentrate the efforts on
their essential tasks, which are the medical management
and follow-up of diabetes.
Finally, the QIP also altered interpersonal relationships.
Most GPs confirmed that the QIP strengthened their rela-
tionships with their patients and improved communica-
tions with specialists and other healthcare providers. They
also perceived a change in attitude on the part of the endo-
crinologists toward them, which markedly enhanced the
GPs' motivation and sense of responsibility. These find-
ings substantiated various theories and research findings
that a positive relationship among healthcare providers is
an important component of high-quality patient care
[31,32].
Nevertheless, limitations of the QIP were also described.
First, according to the interviewees, a significant minority
of patients remained refractory to change, with many
refusing to see a nurse educator. Most patients found it
difficult to change their lifestyle, and even in the case of
motivated individuals the changes were often minimal
and temporary. These findings confirm previous findings
that sustainable lifestyle changes are hard to implement in
clinician-centered models of patient education [18,33-
35]. Moreover, these models are labour- and resource-
intensive [36] and traditionally put the emphasis on
imparting knowledge [37]. Yet, in even the most success-
ful trials of face-to-face education, many participants are
not willing or able to attend the sessions [38,39]. There-
fore, ongoing research evaluates the effect of new models
that are based on peer support. These models put the
emphasis on coping with illness, rather than managing it
[40]. Peer support seeks to build on the strengths, knowl-
edge and experience that peers can offer. Greenhalgh et al.
has tested the effect of a narrative method (a person tell-
ing a story) versus conventional nurse-led education in a
minority ethnic group of people with diabetes [40]. The
results show that unstructured storytelling is associated
with improvement of patients' enablement and compara-
ble changes in biomedical markers. Other self-manage-
ment programs evaluate the effect of other peer support
interventions, like telephone counseling or web-based
peer support. Future QIPs may incorporate peer support
interventions replacing or complementing the traditional
clinician-centered patient education interventions.
At GP-level, four interviewees affirmed not having experi-
enced a major impact of the QIP on their quality of care.Implementation Science 2009, 4:41 http://www.implementationscience.com/content/4/1/41
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In fact, they experienced the QIP somehow as superfluous
because they already paid special attention to evidence-
based diabetes care before the start of the project. The
study also revealed that some GPs were reluctant on to
reorganize their practices to comply with the project's
requirements, or even to find the time for efficient patient
follow-up. Accordingly, future QIPs should specifically
address such issues. Moreover, while the project was
indeed able to induce a change in attitude with regard to
medical diabetes treatment, some other deeply rooted
attitudes were more difficult to change. For example, sev-
eral GPs asserted that nurse educators and other personnel
in the so-called 'soft sector' are of little value in good dia-
betes care. Collaborative shared care with specialists also
remains a concern, despite the improvement that was
observed during the project. One GP reported persistent
problems with one local endocrinologist who was blamed
for his disdainful attitude to general practice. Other GPs
described minor remaining difficulties with endocrinolo-
gists despite overall satisfaction with the arrangements.
These findings complement previously reported difficul-
ties in collaborative shared care. One of the major
reported issues about shared care is the problem of subop-
timal communication between the involved providers
[41]. This problem is associated with discontinuity in care
and lower quality of care [42]. Other problems are related
to lack of clear division of tasks and responsibilities
between the involved providers, eventually leading to
overlap and competing interests [29,43]. Despite these
problems, we think that shared care is necessary to guar-
antee high-quality diabetes care because the management
of this disease is too complex and too broad to have it pro-
vided by one person. However, the aforementioned prob-
lems are a real point of concern. Moreover, as our research
shows, providers are not always willing to collaborate.
Thus QIPs should pay special attention to eventual rela-
tional problems, to communication issues and to the dis-
tribution of rights, responsibilities and tasks between
patients, GPs, nurse educators and specialists.
The role of EBM in daily practice remains a point of con-
troversy. While many GPs accepted the existing guide-
lines, some did not. Some GPs fundamentally disagreed
with EBM. Others accepted EBM as background support,
but were afraid that EBM would be used to impose coer-
cive instructions for daily practice. Several GPs questioned
the feasibility and desirability of the American Diabetes
Association guideline-based recommendations in the eld-
erly or immobile people. Indeed, elderly patients are par-
ticularly sensitive to the adverse effects of drugs and
polypharmacy, putting constraints on the classic diabetes
treatment. In particular, hypoglycemia is an important
topic in the diabetes treatment of elderly people. Recent
studies [44,45] clearly indicate that hypoglycemia may be
a contributing factor to morbidity and mortality in older
patients. As such, strict adherence to guidelines for
younger patients could be deleterious for the frail elderly
[46]. Geriatric guidelines on the management of type 2
diabetes accentuate that treatment should be holistic, tar-
geting all important aspects of the geriatric patients with
priorities in the treatment scheme. Diabetes-related tar-
gets should be individually adapted to the frail patients
with special attention to avoidance of side effects [47-49].
This qualitative research presents some limitations. A first
possible bias concerns the researchers who conducted the
interviews. They were previously involved in the QIP, and
thus they are known by the interviewees as promoters of
this program. As a consequence, GPs in disaccord with
some issues of the QIP-process may have been discour-
aged to mention them. The GP cohort selected for the
study represented an additional limitation. The partici-
pants were part of a larger sample of volunteer GPs who
were particularly interested in the project. This selection
bias may well be reflected in their answers. In order to
generate a broad spectrum of answers regarding barriers to
change, we employed a targeted sampling procedure that
took into account the performance of the GP's practice.
Only their subjective feelings and views are covered here,
although a more balanced picture would have emerged if
a joint patient-provider perspective had been offered. It
remains for future research to include interviews with
patients and, perhaps, employ mixed focus groups, and
audio- or video-record observations of the clinician-
patient encounters. However, despite the possible bias, we
feel this qualitative study has provided a very balanced
overview of the QIP's strengths and weaknesses, and vali-
dated the quantitative findings that had been obtained.
Implications
Previous research revealed numerous barriers to high-
quality diabetes care at the level of provider, patient, and
healthcare organization. However, most of this research
was done outside the context of quality improvement.
Our research reveals the viewpoints of physicians who
experienced a quality improvement process and it allows
for evaluating the complex interactions between barriers
and facilitators during this process. It has become obvious
that implementation of a QIP encounters an array of cog-
nitive, motivational, and relational barriers that are
embedded in a patient-healthcare provider relationship.
As their success may depend on overcoming key barriers,
QIPs should incorporate mechanisms to actively detect
and overcome these barriers or to cope with them. More-
over, several barriers appear to be interdependent, devel-
oping several 'chains of barriers'. This phenomenon may
be a reason why multifaceted QIPs acting on different bar-
riers in a chain are likely to be more effective than single
interventions.Implementation Science 2009, 4:41 http://www.implementationscience.com/content/4/1/41
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Our research particularly revealed the GPs feelings on col-
laborative shared care. While some of them disagree on
the added value of diabetes educators, many GPs feel
some uneasiness regarding the competition with specialist
care. These feelings may be reinforced by the typical Bel-
gian healthcare setting, but we believe that they are the
expression of a very human nature and thus not unique to
the Belgian situation. Literature on this issue, however, is
very scarce. Our research also showed that these negative
assumptions and feelings can be overcome by paying
attention to them and by enhancing the personal contact
and communication between the people involved.
The interviews also revealed the limits of a clinician-cen-
tered model of patient education and self-management,
and confirmed the quantitative results of the study on this
issue. Future QIPs could incorporate and test innovative
patient-centered methods, like different models on peer
support for patients.
Finally, several interviewees reported real concerns on the
applicability of the 'traditional' diabetes guidelines in a
subset of the patient population, namely the elderly.
These concerns have been joined by specific geriatric
guidelines. These findings show that quality improvement
is not a unidirectional process from guideline to practice.
Often, several practitioners express the same difficulties
with implementing a guideline. In that case, it might actu-
ally reveal a flaw in that guideline rather than a barrier
related to the practitioners. And thus QIPs should also be
used as instruments to test the feasibility of guidelines as
well as to highlight any flaws.
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Appendix
Interventions of the quality improvement program
Interventions in support of the GP
- Diffusion of a Evidence-based treatment protocol with
clear recommendations on:
1. Timely follow-up (every three months), with atten-
tion to all important parameters (biological risk fac-
tors and early signs of complications).
2. Global treatment with attention for:
a. Glycaemia control, blood pressure control and
blood lipids control.
b. Comprehensive treatment.
i. Healthy lifestyle habits.
ii. Comprehensive drugs treatment including
anti-platelet therapy, BP treatment with ACE-
inhibition, and statin therapy.
3. Target-driven treatment (7% for HbA1c <7%, SBP ≤
130 mm Hg, LDL-C <100 mg/dl) with treatment
intensification whenever the targets are not reached.
4. Task description:
a. The GP receives the overall responsibility for the
management of diabetes patients. If the GP does
not succeed in reaching the targets, he or she can
call for help by referring to partners in the diabetes
care (interdisciplinary diabetes care team, or IDCT,
or hospital-based diabetes clinics).
b. The IDCT functions in support of the GP when-
ever treatment targets were not reached.
c. The hospital-based diabetes clinic should treat
patients with case of complications and with com-
plex insulin therapy schemes.
- Clinician education and coaching
a. postgraduate educational sessions on:
i. the evidence-based treatment of T2DM
patients, according to the treatment protocol,
with special attention to the principles of glo-
bal cardiovascular treatment and the target
driven approach.
ii. the initiation and adjustment of insulin ther-
apy in general practice.
b. Case coaching by the endocrinologist: the GP
can call for help by mail or by phone regarding
treatment schemes of individual patients without
referring them to the specialist.
- Feedback: benchmarking feedback: each GP receives
feedback on the treatment schemes and on the outcomes
of patients of his or her practice in comparison with the
results of the entire group.Implementation Science 2009, 4:41 http://www.implementationscience.com/content/4/1/41
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- Incentives: €60 for each included patient; involvement
of opinion leaders (endocrinologist from the University
Hospital)
Interventions in support of the patient
- Availability of patient education by a nurse educator, a
dietician, or a general internist working together in one
IDCT, upon referral by the GP
- Availability of Home Blood Glucose Material for
patients with insulin therapy initiated by the GP and the
IDCT
Organizational interventions
- Team changes: the IDCT was newly created and acted on
the interface between primary and specialist care. The
team consisted of a general internist, a diabetes educator
(this intervention is innovative in Belgian primary care)
and a dietician. It could only be counselled upon referral
by the GP and was supervised by the endocrinologist of
the hospital-based diabetes clinic and her team trough bi-
monthly joint team meetings.
- Timely data collection: GPs are asked (by mail and by
phone) to deliver diabetes related patient data every three
months.
IDCT = Interdisciplinary Diabetes Care Team (endocrinol-
ogist, nurse educator, dietician) installed at the primary
care level
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